Background illustration for clinical trials search

Paid Clinical Trials Salem

Discover 955 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

for
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Location: Portland OR, Stanford CA, Salt Lake City UT,
Sponsor: Duke University

Sex: All

Age: 21+

Code: NCT01915511

Recruiting
Active & Responsive

A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease

for
Degenerative Disc Disease
Location: Eugene OR, San Diego CA, Post Falls ID,
Sponsor: DiscGenics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07254806

Phase 3, Recruiting
Active & Responsive

Testing Just-in-Time Adaptive Interventions (JITAIs) to Prevent Goal Disengagement in Response to Weight Regain

for
Overweight or Obesity
Location: Springfield OR
Sponsor: ORI Community and Evaluation Services

Sex: All

Age: 18 - 70+

Code: NCT07708064

Recruiting
Active & Responsive

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

for
HR+ HER2- Breast Cancer
Location: Springfield OR, Los Angeles CA, Lone Tree CO, Austin TX,
Sponsor: Faeth Therapeutics

Sex: All

Age: 18+

Code: NCT07558733

Phase 1, Phase 2, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Salem OR, Olympia WA, Tacoma WA, Medford OR, Seattle WA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

for
Myelodysplastic Syndromes, Acute Myeloid Leukemia,
Location: Salem OR, Portland OR, Seattle WA, Los Angeles CA,
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT04256317

Phase 2, Phase 3, Recruiting

GEMINI-NSCLC: NSCLC Biomarker Study

for
Non-Small Cell Lung Cancer
Location: Salem OR, Bellingham WA, Spokane Valley WA, Reno NV,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT05236114

Recruiting

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

for
HR+/HER2- Breast Cancer
Location: Salem OR, Eugene OR, Olympia WA, Tacoma WA, Yakima WA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07492641

Phase 3, Recruiting

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

for
Breast Neoplasms
Location: Salem OR, Portland OR, Redmond OR, Bend OR, Tacoma WA,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07173751

Phase 3, Recruiting

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Salem OR, Tacoma WA, San Francisco CA, Los Angeles CA,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07213674

Phase 3, Recruiting

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

for
Metastatic Gastric Adenocarcinoma,
Location: Salem OR, Tacoma WA, Las Vegas NV, Los Alamitos CA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07043400

Phase 3, Recruiting

CtDNA Based MRD Testing for NAC Monitoring in TNBC

for
TNBC - Triple-Negative Breast Cancer, Minimal Residual Disease
Location: Salem OR, Spokane WA, Aurora CO, Tucson AZ, Omaha NE,
Sponsor: Personalis Inc.

Sex: Female

Age: 18+

Code: NCT06230185

Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: Salem OR, Vancouver WA, Eugene OR, Vancouver,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase 2, Phase 3, Recruiting

E-Mindfulness Approaches for Living After Breast Cancer

for
Breast Cancer, Depression
Location: Salem OR, Newberg OR, Oregon City OR, Portland OR,
Sponsor: NRG Oncology

Sex: All

Age: 18 - 50

Code: NCT06748222

Phase 3, Recruiting

Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)

for
Middle Schools, School Exclusion, School Community,
Location: Salem OR, Yuba City CA, Capitola CA
Sponsor: University of Oregon

Sex: All

Age: 8 - 15

Code: NCT06292078

Recruiting

Use of a Novel Device for Stretch Relaxation During Mohs Surgery

for
Tissue Expander Disorder, Stress Strain Curve, Tissue Expansion,
Location: Salem OR
Sponsor: Silver Falls Dermatology

Sex: All

Age: 18+

Code: NCT03586960

Recruiting

Mobility Rehab, a Therapist-assisted System for Gait Rehabilitation

for
Parkinson Disease, Stroke, Multiple Sclerosis,
Location: Salem OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 60 - 70+

Code: NCT03869879

Recruiting

Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age

for
Amblyopia
Location: Albany OR, Portland OR, Spokane WA, Sacramento CA,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 8 - 12

Code: NCT06524882

Phase 3, Recruiting

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

for
Amblyopia
Location: Albany OR, Portland OR, Seattle WA, Spokane WA,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 3 - 13

Code: NCT04378790

Phase 3, Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Fruitland ID, Caldwell ID, Nampa ID, Meridian ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase 3, Recruiting